Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project

Figure 2

IgG-class antibody levels (median/75-percentiles) in IgG-positive patients with and without IgA-class antibodies against cyclic citrullinated peptides. Box plots illustrating the median IgG-class antibodies against cyclic citrullinated peptides (IgG anti-CCP) levels as well as the 75th percentiles and total ranges among the IgG-positive patients with positive IgA-class antibodies against cyclic citrullinated peptides (IgA anti-CCP) tests.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us